日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancer

探索既往接受过治疗的 HR+/HER2- 和三阴性转移性乳腺癌患者的真实世界结局

Sadetsky, Natalia; Prince, Patricia; Latimer, Helen; Advani, Pooja; Smith-Gaziani, Demetria; Kaufman, Peter A; Natanzon, Yanina; Taylor, Aliki; Nguyen, Linda; Freemantle, Nick

Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women with HR+/HER2- Metastatic Breast Cancer

HR+/HER2-转移性乳腺癌女性一线治疗及预后模式的社会人口学差异

Vidal, Gregory A; Katz, Julie; Sadetsky, Natalia; Dabrowski, Elizabeth C; Kaufman, Peter A; Verret, Wendy; Stwalley, Brian; Kalinsky, Kevin

Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2- metastatic breast cancer using real-world data in France and Germany

利用法国和德国的真实世界数据,分析接受化疗的HR+/HER2-转移性乳腺癌患者的治疗模式和临床结果

Campone, Mario; Frenel, Jean-Sebastien; Kiver, Verena I I; Woeckel, Achim; Kerscher, Alexander; Krebs, Markus; Leal, Cátia; Saglimbene, Valeria M; Ann, Quratul; Sadetsky, Natalia; Sjekloca, Nikoleta; Libert, Olivier; Kaushik, Ankita; Bocquet, Francois

Effectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States

在美国真实世界环境中,sacituzumab govitecan 对转移性三阴性乳腺癌患者中性粒细胞减少症的疗效及管理

Nanda, R; Yam, C; Spring, L; Bhave, M A; Ntalla, I; Valdez, T; Stwalley, B; Liang, C; Wu, W-H; Sjekloca, N; Sadetsky, N; Lai, C; Kalinsky, K

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

接受利妥昔单抗治疗失败后,EBV阳性PTLD患者在异基因造血干细胞移植后的预后

Socié, Gérard; Barba, Pere; Barlev, Arie; Sanz, Jaime; García-Cadenas, Irene; Chevallier, Patrice; Fagioli, Franca; Guzman-Becerra, Norma; Kumar, Deepali; Ljungman, Per; Pigneux, Arnaud; Sadetsky, Natalia; Yáñez San Segundo, Lucrecia; Shadman, Mazyar; Storek, Jan; Thirumalai, Dhanalakshmi; Xing, Baodong; Mohty, Mohamad

Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV(+) PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study

专家共识:对于可能不适合接受标准剂量化疗的EB病毒阳性移植后淋巴增殖性疾病(EBV(+) PTLD)患者,其特征有哪些?一项改良的德尔菲研究

Chaganti, Sridhar; Barlev, Arie; Caillard, Sophie; Choquet, Sylvain; Cwynarski, Kate; Friedetzky, Anke; González-Barca, Eva; Sadetsky, Natalia; Schneeberger, Stefan; Thirumalai, Dhanalakshmi; Zinzani, Pier L; Trappe, Ralf U

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data

利用真实世界数据在非小细胞肺癌临床试验的化疗组中验证总生存期、无进展生存期和总体缓解率

Ton, Thanh G N; Pal, Navdeep; Trinh, Huong; Mahrus, Sami; Bretscher, Michael T; Machado, Robson J M; Sadetsky, Natalia; Chaudhary, Nayan; Lu, Michael W; Riely, Gregory J

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study

黑色素瘤合并中枢神经系统转移患者的治疗模式和临床结局:一项真实世界研究

Tawbi, Hussein; To, Tu My; Bartley, Karen; Sadetsky, Natalia; Burton, Elizabeth; Haydu, Lauren; McKenna, Edward

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis

美国老年人群中晚期黑色素瘤和中枢神经系统转移患者的生存结局:SEER-Medicare 分析

Sadetsky, Natalia; Hernandez, Alexandra; Wallick, Chris J; McKenna, Edward F; Surinach, Andy; Colburn, Dawn E

Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™

叶酸摄入量对前列腺癌根治性治疗后复发的影响:来自 CaPSURE™ 的数据

Tomaszewski, Jeffrey J; Richman, Erin L; Sadetsky, Natalia; O'Keefe, Denise S; Carroll, Peter R; Davies, Benjamin J; Chan, June M